Literature DB >> 2317327

Carotid body paragangliomas. A clinicopathologic and DNA analysis of 13 tumors.

L Barnes1, S R Taylor.   

Abstract

The clinical and pathological features of 13 carotid body paragangliomas from 12 patients were examined and correlated with the DNA ploidy pattern as determined by image analysis. These tumors occurred in 7 women and 5 men aged 19 to 62 years (average, 42 years). All presented with a slowly enlarging, usually asymptomatic mass of 2 weeks' to 25 years' duration. Two patients were related and had a family history of paragangliomas. The tumors ranged from 2 to 6 cm. All contained scattered chief cells with pleomorphic nuclei, two exhibited mitoses, and three showed perineural and three vascular invasion. Follow-up was available in all 12 patients and ranged from 15 months to 28 years (average, 7.3 years). None of the tumors recurred locally, but one did metastasize to a single cervical lymph node that was apparent at the time of diagnosis. Of 13 carotid body paragangliomas examined for DNA, 4 were diploid, 3 diploid-tetraploid, 3 tetraploid, 2 aneuploid, and 1 polyploid. The only malignant tumor was polyploid. From these observations, we conclude that abnormalities in DNA content of carotid body paragangliomas are common and that tumor ploidy cannot be used to assess malignant potential. We also found no apparent relationship among nuclear pleomorphism, mitotic activity, perineural invasion, or vascular invasion and clinical behavior. Perineural and vascular invasion, however, were observed only in tumors with abnormal DNA histograms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317327     DOI: 10.1001/archotol.1990.01870040069016

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  18 in total

1.  Studies for estimating the biologic behavior and prognosis of paragangliomas in the head and neck.

Authors:  H J Welkoborsky; Y Xiao; W J Mann; R G Amedee; H P Dienes; B Volk
Journal:  Skull Base Surg       Date:  1995

2.  Angiofibroma: a flow cytometric evaluation of 31 cases.

Authors:  L Barnes; P C Weber; J Krause; L Contis; I Janecka
Journal:  Skull Base Surg       Date:  1992

3.  Primary parapharyngeal tumours: a review of 21 cases.

Authors:  Claudio Caldarelli; S Bucolo; R Spisni; D Destito
Journal:  Oral Maxillofac Surg       Date:  2014-04-24

4.  Locally Aggressive Primary Intraosseous Paraganglioma of Sacrum.

Authors:  Parampalli Srinivas Srilatha; Lakshmi Rao
Journal:  J Clin Diagn Res       Date:  2017-09-01

5.  Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.

Authors:  Hilary C McCrary; Eric Babajanian; Matias Calquin; Patrick Carpenter; Geoffrey Casazza; Anne Naumer; Samantha Greenberg; Wendy Kohlmann; Richard Cannon; Marcus M Monroe; Jason P Hunt; Luke Buchmann
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-07-01       Impact factor: 6.223

Review 6.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Cerebellopontine angle paraganglioma - report of a case and review of literature.

Authors:  Prabal Deb; Mehar Chand Sharma; Shailesh Gaikwad; Aditya Gupta; Veer Singh Mehta; Chitra Sarkar
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

8.  CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas).

Authors:  Anju Sahdev; A Sohaib; John P Monson; Ashley B Grossman; Shern L Chew; Rodney H Reznek
Journal:  Eur Radiol       Date:  2004-07-28       Impact factor: 5.315

Review 9.  [Glomus tumors of the head-neck-region].

Authors:  C Axmann; U Dorenbeck; W Reith
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

Review 10.  [Dignity of carotid body tumors. Review of the literature and clinical experiences].

Authors:  D Grotemeyer; S M Loghmanieh; S Pourhassan; T A Sagban; F Iskandar; P Reinecke; W Sandmann
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.